ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...
Please provide your email address to receive an email when new articles are posted on . The Emboliner embolic protection device showed noninferiority vs. the Sentinel device during TAVR. The new ...
Elective carotid artery angioplasty and stenting was initiated in the United States in 1994 by the endovascular interventional team at the University of Alabama at Birmingham. Carotid stenting was ...
"The reasons for these findings likely represent our lack of a complete understanding of the factors involved in no-reflow/distal embolization phenomena." The use of a distal embolic protection device ...
MILAN, March 15, 2017 /PRNewswire/ -- Innovative Cardiovascular Solutions (ICS), a privately held medical device company pioneering novel solutions for embolic protection during transcatheter aortic ...
€2.1M Grant to support Filterlex's CAPTIS clinical trials YOKNEAM, Israel, Sept. 16, 2019 /PRNewswire/ -- Filterlex Medical, an innovative medical device startup in the cardiovascular field, today ...
A multicenter EPIC (FiberNet® Embolic Protection System in Carotid Artery Stenting Trial) study found that the FiberNet Embolic Protection System (EPS) had a 97.5% success rate when used in patients ...
A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results